skip navigation
´ë¸Þ´º ¹Ù·Î°¡±â
º»¹®³»¿ë ¹Ù·Î°¡±â
ÅëÇÕ°Ë»ö
¾àÁ¦ÆÀ¼Ò°³
Àλ縻
Á¶Á÷µµ
¾÷¹«¼Ò°³
¿¬Çõ
ã¾Æ¿À½Ã´Â ±æ
¾à¹°Á¤º¸
´º½º·¹ÅÍ
º¹¾àÁöµµ
±³À°¡¤¿¬±¸
Á¤±Ô¾à»ç±³À°
½Å±Ô¾à»ç±³À°
¾à´ë»ý±³À°
¿ÜºÎ¾à»ç±³À°
ÇÐȸ¹ßÇ¥ÀÚ·á
°Ô½ÃÆÇ
°øÁö»çÇ×
Àαپ౹°Ô½ÃÆÇ
¾àÁ¦ÆÀÄ«Æä
¼½Ä¸ðÀ½
FAQ
¾à¹°Á¤º¸
´º½º·¹ÅÍ
´º½º·¹ÅÍ PDF ¸ñ·Ï
½Å¾à¼Ò°³
Pharmacotherapy
¾ÈÀü¼ºÁ¤º¸
°Ç°»ó½Ä
¾àÁ¦ÆÀ NEWS
pdf º¸±â
Áö³È£ º¸±â
º¹¾àÁöµµ
ÇØ´ç ½ºÅ©¸³Æ®°¡ Á¤»óÀûÀ¸·Î ÀÛµ¿ÇÏÁö ¾Ê½À´Ï´Ù. ºÒÆíÀ» µå·Á¼ Á˼ÛÇÕ´Ï´Ù.
Pharmacotherapy
¾àÁ¦ÆÀ
¾à¹°Á¤º¸
´º½º·¹ÅÍ
Pharmacotherapy
±â±Ý¼Ò½Ä ¸ñ·Ï
¹øÈ£
Á¦¸ñ
ÀÛ¼ºÀÚ
³¯Â¥
Á¶È¸
81
¡Ø2018³â 1¿ùºÎÅÍ´Â ´º½º·¹ÅÍ PDF ¸ñ·Ï¿¡¼ Á¦°øÇÕ´Ï´Ù.
¾àÁ¦ÆÀ
2018-02-28
916
80
17.12.Osimertinib in Untreated EGFR-Mutated Advanced Non£¿Small-Cell Lung Cancer
¾àÁ¦ÆÀ
2018-01-09
1216
79
17.11.Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
¾àÁ¦ÆÀ
2017-12-15
994
78
17.10.Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
¾àÁ¦ÆÀ
2017-11-06
1026
77
17.09.Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
¾àÁ¦ÆÀ
2017-10-13
928
76
17.08.Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
¾àÁ¦ÆÀ
2017-09-07
859
75
17.07.Idarucizumab for Dabigatran Reversal - Full Cohort Analysis
¾àÁ¦ÆÀ
2017-08-04
1055
74
17.06.Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes
¾àÁ¦ÆÀ
2017-07-19
1072
73
17.05.Angiotensin II for the Treatment of Vasodilatory Shock
¾àÁ¦ÆÀ
2017-06-15
1129
72
17.04.Palbociclib and Letrozole in Advanced Breast Cancer
¾àÁ¦ÆÀ
2017-05-24
1150
1
2
3
4
5
6
7
8
9
°Ë»ö
Á¦¸ñ
³»¿ë
ÀÛ¼ºÀÚ
ã¾Æ¿À½Ã´Â ±æ
´º½º·¹ÅÍ